Viewing Study NCT04042402


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2025-12-26 @ 2:55 AM
Study NCT ID: NCT04042402
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-30
First Post: 2019-07-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Long Term Extension Study in Patients With Primary Hyperoxaluria
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module